Home Cart Sign in  
Chemical Structure| 38183-03-8 Chemical Structure| 38183-03-8

Structure of 7,8-Dihydroxyflavone
CAS No.: 38183-03-8

Chemical Structure| 38183-03-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

7,8-Dihydroxyflavone acts as an agonist of TrkB receptor with Kd of 320 nM with neuroprotective effect.

Synonyms: 7,8-DHF

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 7,8-Dihydroxyflavone

CAS No. :38183-03-8
Formula : C15H10O4
M.W : 254.24
SMILES Code : OC1=CC=C2C(=O)C=C(OC2=C1O)C1=CC=CC=C1
Synonyms :
7,8-DHF
MDL No. :MFCD00006836
InChI Key :COCYGNDCWFKTMF-UHFFFAOYSA-N
Pubchem ID :1880

Safety of 7,8-Dihydroxyflavone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of 7,8-Dihydroxyflavone

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary hippocampal neurons 250 nM Activate TrkB receptor PMC4702337
Neonatal rat ventricular myocytes (NRVMs) 100 nM 10 min 7,8-DHF increased ERK phosphorylation levels, similar to LM22A-4 PMC10281793
Adult murine ventricular myocytes 2.5 μM, 5 μM, 10 μM 7,8-DHF dose-dependently increased sarcomere shortening and whole Ca2+ transient, similar to LM22A-4 PMC10281793
Primary cortical neurons 500 nM 3 days 7,8-DHF significantly increased the total dendritic length and branching complexity of neurons. PMC3895241
Locus coeruleus (LC) neurons 500 nM 18 h 7,8-DHF significantly reduced Aβ-induced neuronal apoptosis, protecting neurons from Aβ toxicity. PMC3895241
Rat primary cortical neurons 500 nM 18 h 7,8-DHF significantly reduced Aβ-induced neuronal apoptosis, protecting neurons from Aβ toxicity. PMC3895241

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Traumatic brain injury model Intraperitoneal or oral administration 5 mg/kg Administration at 3 hours post-injury Reduce brain tissue damage PMC4702337
Mice 5XFAD transgenic mouse model of AD Oral (via drinking water) 5 mg/kg Daily administration for 4 months 7,8-DHF activated TrkB signaling pathways, reduced Aβ deposition, prevented hippocampal synaptic loss, restored synaptic plasticity, and improved spatial memory deficits. PMC3895241

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.93mL

0.79mL

0.39mL

19.67mL

3.93mL

1.97mL

39.33mL

7.87mL

3.93mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories